Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine. more
Time Frame | ICCC | Sector | S&P500 |
---|---|---|---|
1-Week Return | -10.37% | -2.12% | -3% |
1-Month Return | 22.5% | -3.42% | -0.73% |
3-Month Return | 22.5% | -11.13% | 2.87% |
6-Month Return | 1.38% | -5.74% | 7.17% |
1-Year Return | -7.93% | 3.97% | 25.31% |
3-Year Return | -49.83% | 1.05% | 28.38% |
5-Year Return | -14.37% | 34.37% | 81.89% |
10-Year Return | -11.8% | 97.88% | 183.27% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 13.72M | 15.34M | 19.24M | 18.57M | 17.47M | [{"date":"2019-12-31","value":71.31,"profit":true},{"date":"2020-12-31","value":79.73,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":96.49,"profit":true},{"date":"2023-12-31","value":90.79,"profit":true}] |
Cost of Revenue | 6.98M | 8.48M | 10.59M | 10.92M | 13.08M | [{"date":"2019-12-31","value":53.41,"profit":true},{"date":"2020-12-31","value":64.85,"profit":true},{"date":"2021-12-31","value":80.97,"profit":true},{"date":"2022-12-31","value":83.51,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 6.74M | 6.86M | 8.66M | 7.65M | 4.40M | [{"date":"2019-12-31","value":77.87,"profit":true},{"date":"2020-12-31","value":79.29,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":88.37,"profit":true},{"date":"2023-12-31","value":50.79,"profit":true}] |
Gross Margin | 49.11% | 44.73% | 44.98% | 41.19% | 25.16% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":91.08,"profit":true},{"date":"2021-12-31","value":91.59,"profit":true},{"date":"2022-12-31","value":83.87,"profit":true},{"date":"2023-12-31","value":51.23,"profit":true}] |
Operating Expenses | 7.69M | 8.24M | 8.40M | 9.95M | 9.62M | [{"date":"2019-12-31","value":77.34,"profit":true},{"date":"2020-12-31","value":82.86,"profit":true},{"date":"2021-12-31","value":84.43,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":96.68,"profit":true}] |
Operating Income | (954.00K) | (1.38M) | (2.20M) | (2.30M) | (5.75M) | [{"date":"2019-12-31","value":-95400000,"profit":false},{"date":"2020-12-31","value":-138000000,"profit":false},{"date":"2021-12-31","value":-220414000,"profit":false},{"date":"2022-12-31","value":-229900000,"profit":false},{"date":"2023-12-31","value":-574807800,"profit":false}] |
Total Non-Operating Income/Expense | (627.50K) | (37.25K) | (622.06K) | (382.44K) | (294.87K) | [{"date":"2019-12-31","value":-62750500,"profit":false},{"date":"2020-12-31","value":-3724700,"profit":false},{"date":"2021-12-31","value":-62206100,"profit":false},{"date":"2022-12-31","value":-38243600,"profit":false},{"date":"2023-12-31","value":-29487200,"profit":false}] |
Pre-Tax Income | (1.27M) | (1.03M) | (69.00K) | (2.49M) | (5.77M) | [{"date":"2019-12-31","value":-126800000,"profit":false},{"date":"2020-12-31","value":-103200000,"profit":false},{"date":"2021-12-31","value":-6900000,"profit":false},{"date":"2022-12-31","value":-248600000,"profit":false},{"date":"2023-12-31","value":-576997100,"profit":false}] |
Income Taxes | 28.00K | (10.00K) | 9.00K | 8.00K | 4.63K | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-35.71,"profit":false},{"date":"2021-12-31","value":32.14,"profit":true},{"date":"2022-12-31","value":28.57,"profit":true},{"date":"2023-12-31","value":16.52,"profit":true}] |
Income After Taxes | (1.30M) | (1.02M) | (78.00K) | (2.49M) | (5.77M) | [{"date":"2019-12-31","value":-129600000,"profit":false},{"date":"2020-12-31","value":-102200000,"profit":false},{"date":"2021-12-31","value":-7800000,"profit":false},{"date":"2022-12-31","value":-249400000,"profit":false},{"date":"2023-12-31","value":-577459800,"profit":false}] |
Income From Continuous Operations | (1.30M) | (1.02M) | (78.00K) | (2.49M) | (6.30M) | [{"date":"2019-12-31","value":-129558700,"profit":false},{"date":"2020-12-31","value":-102200000,"profit":false},{"date":"2021-12-31","value":-7800000,"profit":false},{"date":"2022-12-31","value":-249400000,"profit":false},{"date":"2023-12-31","value":-630263300,"profit":false}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | (1.30M) | (1.02M) | (78.00K) | (2.49M) | (5.77M) | [{"date":"2019-12-31","value":-129600000,"profit":false},{"date":"2020-12-31","value":-102200000,"profit":false},{"date":"2021-12-31","value":-7800000,"profit":false},{"date":"2022-12-31","value":-249400000,"profit":false},{"date":"2023-12-31","value":-577459800,"profit":false}] |
EPS (Diluted) | (0.19) | (0.14) | (0.03) | (0.40) | (0.39) | [{"date":"2019-12-31","value":-19,"profit":false},{"date":"2020-12-31","value":-14,"profit":false},{"date":"2021-12-31","value":-3,"profit":false},{"date":"2022-12-31","value":-40.46,"profit":false},{"date":"2023-12-31","value":-38.71,"profit":false}] |
These ratios help you determine the liquidity of the company. Higher is better.
ICCC | |
---|---|
Cash Ratio | 0.85 |
Current Ratio | 3.11 |
Quick Ratio | 1.44 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
ICCC | |
---|---|
ROA (LTM) | -4.87% |
ROE (LTM) | -16.10% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
ICCC | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.41 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.59 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
ICCC | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 1.76 |
P/B | 1.55 |
Price/FCF | NM |
EV/R | 2.20 |
EV/Ebitda | NM |
PEG | NM |
ImmuCell Corporation (ICCC) share price today is $4.41
Yes, Indians can buy shares of ImmuCell Corporation (ICCC) on Vested. To buy ImmuCell Corporation from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in ICCC stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of ImmuCell Corporation (ICCC) via the Vested app. You can start investing in ImmuCell Corporation (ICCC) with a minimum investment of $1.
You can invest in shares of ImmuCell Corporation (ICCC) via Vested in three simple steps:
The 52-week high price of ImmuCell Corporation (ICCC) is $5.82. The 52-week low price of ImmuCell Corporation (ICCC) is $3.34.
The price-to-earnings (P/E) ratio of ImmuCell Corporation (ICCC) is
The price-to-book (P/B) ratio of ImmuCell Corporation (ICCC) is 1.55
The dividend yield of ImmuCell Corporation (ICCC) is 0.00%
The market capitalization of ImmuCell Corporation (ICCC) is $32.08M
The stock symbol (or ticker) of ImmuCell Corporation is ICCC